An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing

RNA

Volumn 16, Issue 6, 2010, Pages 1167-1181

  Singh, Natalia N ^a   Hollinger, Katrin ^a   Bhattacharya, Dhruva ^a   Singh, Ravindra N ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Alternative splicing; Antisense oligonucleotide; ASO; Exon 7; GC rich; Intron 7; ISS N1; SMA; SMN

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY RNA; CYTOSINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MESSENGER RNA; SINGLE STRANDED RNA; SURVIVAL MOTOR NEURON PROTEIN 2;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EXON; HUMAN; INFANT; INTRON; MUTATION; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY; WILD TYPE;

BASE PAIRING; BASE SEQUENCE; EVOLUTION; EXONS; GENOME, HUMAN; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; INTRONS; MUTATION; OLIGONUCLEOTIDES, ANTISENSE; RNA PRECURSORS; RNA SPLICING; RNA, ANTISENSE; SEQUENCE DELETION; SURVIVAL OF MOTOR NEURON 2 PROTEIN;

EID: 77952676947     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.2154310     Document Type: Article

References (47)

1. Bartel DP, Zapp ML, Green MR, Szostak JW. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67: 529-536.
2. Bauman J, Jearawiriyapaisarn N, Kole R. 2009. Therapeutic potential of splice-switching oligonucleotides. Oligonucleotides 19: 1-14.
3. Buratti E, Baralle M, Baralle FE. 2006. Defective splicing, disease and therapy: Searching for master checkpoints in exon definition. Nucleic Acids Res 34: 3494-3510.
4. Buratti E, Dhir A, Lewandowska MA, Baralle FE. 2007. RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events. Nucleic Acids Res 35: 4369-4383. (Pubitemid 47248459)
5. Burge CB, Tuschl T, Sharp PA. 1999. Splicing of precursors to mRNAs by the spliceosomes. In The RNA world (ed. RF Gesteland et al.), 2nd ed., pp. 525-560. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
6. Chasin LA. 2007. Searching for splicing motifs. Adv Exp Med Biol 623: 85-106.
7. Cooper TA, Wan L, Dreyfuss G. 2009. RNA and disease. Cell 136: 777-793.
8. David CJ, Manley JL. 2008. The search for alternative splicing regulators: New approaches offer a path to a splicing code. Genes Dev 22: 279-285.
9. Garcia-Blanco MA. 2006. Alternative splicing: Therapeutic target and tool. Prog Mol Subcell Biol 44: 47-64.
10. Gladman JT, Chandler DS. 2009. Intron 7 conserved sequence elements regulate the splicing of the SMN genes. Hum Genet 126: 833-841.
11. Golas MM, Sander B, Will CL, Lührmann R, Stark H. 2005. Major conformational change in the complex SF3b upon integration into the spliceosomal U11/U12 di-snRNP as revealed by electron cryomicroscopy. Mol Cell 17: 869-883. (Pubitemid 40386947)
12. Graveley BR. 2005. Mutually exclusive splicing of the insect Dscam pre-mRNA directed by competing intronic RNA secondary structures. Cell 123: 65-73.
13. Grainger RJ, Beggs JD. 2005. Prp8 protein: At the heart of the spliceosome. RNA 11: 533-557.
14. Hertel KJ. 2008. Combinatorial control of exon recognition. J Biol Chem 283: 1211-1215.
15. Hua Y, VickersTA,OkunolaHL,BennettCF,KrainerAR. 2008.Antisense masking of an hnRNP A1/A2 intronic splicing silencer correctsSMN2 splicing in transgenic mice. Am J Hum Genet 82: 834-848.
16. LaBranche H, Dupuis S, Ben-David Y, Bani MR, Wellinger RJ, Chabot B. 1998. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet 19: 199-202. (Pubitemid 28253328)
17. Lardelli RM, Thompson JX, Yates JR 3rd, Stevens SW. 2010. Release of SF3 from the intron branchpoint activates the first step of premRNA splicing. RNA 16: 516-528.
18. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, et al. 1995. Identification and characterization of a spinal muscular atrophydetermining gene. Cell 80: 1-5. (Pubitemid 26003351)
19. Lin S, Fu XD. 2007. SR proteins and related factors in alternative splicing. Adv Exp Med Biol 623: 107-122.
20. Martinez-Contreras R, Cloutier P, Shkreta L, Fisette JF, Revil T, Chabot B. 2007. hnRNP proteins and splicing control. Adv Exp Med Biol 623: 123-147.
21. Matlin AJ, Moore MJ. 2007. Spliceosome assembly and composition. Adv Exp Med Biol 623: 14-35.
22. Matsuura M, Noah JW, Lambowitz AM. 2001. Mechanism of maturase-promoted group II intron splicing. EMBO J 20: 7259-7270. (Pubitemid 34062317)
23. Newman AJ, Nagai K. 2010. Structural studies of the spliceosome: Blind men and an elephant. Curr Opin Struct Biol 20: 82-89.
24. Nilsen TW. 2003. The spliceosome: The most complex macromolecular machine in the cell. Bioessays 25: 1147-1149.
25. Nilsen TW, Graveley BR. 2010. Expansion of eukaryotic proteome by alternative splicing. Nature 463: 457-463.
26. Ooms M, Verhoef K, Southern E, Huthoff H, Berkhout B. 2004. Probing alternative foldings of the HIV-1 leader RNA by antisense oligonucleotide scanning arrays. Nucleic Acids Res 32: 819-827. (Pubitemid 38263075)
27. Shepard PJ, Hertel KJ. 2008. Conserved RNA secondary structures promote alternative splicing. RNA 14: 1463-1469.
28. Singh RN. 2007a. Unfolding the mystery of alternative splicing through a unique method of in vivo selection. Front Biosci 12: 3263-3272.
29. Singh RN. 2007b. Evolving concepts on human SMN pre-mRNA splicing. RNA Biol 4: 7-10.
30. Singh NN, Androphy EJ, Singh RN. 2004a. The regulation and regulatory activities of alternative splicing of the SMN gene. Crit Rev Eukaryot Gene Expr 14: 271-285.
31. Singh NN, Androphy EJ, Singh RN. 2004b. An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. Biochem Biophys Res Commun 315: 381-388.
32. Singh NN, Androphy EJ, Singh RN. 2004c. In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes. RNA 10: 1291-1305.
33. Singh NK, Singh NN, Androphy EJ, Singh RN. 2006. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol Cell Biol 26: 1333-1346.
34. Singh NN, Singh RN, Androphy EJ. 2007. Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes. Nucleic Acids Res 35: 371-389.
35. Singh NN, Shishimorova M, Cao LC, Gangwani L, Singh RN. 2009. A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy. RNA Biol 6: 341-350.
36. Smith DJ, Query CC, Konarska MM. 2008. 'Nought may endure but mutability': Spliceosome dynamics and the regulation of splicing. Mol Cell 30: 657-666.
37. Tazi J, Bakkour N, Stamm S. 2009. Alternative splicing and disease. Biochim Biophys Acta 1792: 14-26.
38. Veedu RN, Wengel J. 2009. Locked nucleic acid as a novel class of therapeutic agents. RNA Biol 6: 321-323.
39. Vitte J, Fassier C, Tiziano FD, Dalard C, Soave S, Roblot N, Brahe C, Saugier-Veber P, Bonnefont JP, Melki J. 2007. Refined characterization of the expression and stability of the SMN gene products. Am J Pathol 171: 1269-1280. (Pubitemid 47582900)
40. Wahl MC, Will CL, Lührmann R. 2009. The spliceosome: Design principles of a dynamic RNP machine. Cell 136: 701-718.
41. Wang Z, Burge CB. 2008. Splicing regulation: From a parts list of regulatory elements to an integrated splicing code. RNA 14: 802-813. (Pubitemid 351574901)
42. Ward AJ, Cooper TA. 2010. The pathology of splicing. J Pathol 220: 152-163.
43. Warf MB, Diegel JV, von Hippel PH, Berglund JA. 2009. The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing. Proc Natl Acad Sci 106: 9203-9208.
44. Williams JH, Schray RC, Patterson CA, Ayitey SO, Tallent MK, Lutz GJ. 2009. Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy. J Neurosci 29: 7633-7638.
45. Wirth B, Brichta L, Hahnen E. 2006. Spinal muscular atrophy and therapeutic prospects. Prog Mol Subcell Biol 44: 109-132.
46. Xing Y, Lee C. 2007. Relating alternative splicing to proteome complexity and genome evolution. Adv Exp Med Biol 623: 36-49.
47. Yu Y, Maroney PA, Denker JA, Zhang XH, Dybkov O, Lührmann R, Jankowsky E, Chasin LA, Nilsen TW. 2008. Dynamic regulation of alternative splicing by silencers that modulate 5′ splice site competition. Cell 135: 1224-1236.